Announcement on Changing Signatory Certified Public Accountant
Filed with SSE · · 2 pages · Chinese
Shanghai Serum Bio-Technology Co., Ltd. on 6ix
Earlier from Shanghai Serum Bio-Technology
- Announcement on Attending Three-Quarter Report Collective Performance Briefing of Listed Companies in Shanghai Jurisdiction in 2025
- Report for Q3 2025
- Announcement on Implementation of Semi-annual Dividend Distribution for 2025
- Announcement on Attending Semi-annual Collective Performance Briefing for Enterprises in Biological Products and CXO Industries on SSE STAR Market 2025
- Announcement on Listing and Circulation of Restricted Shares in Initial Public Offering
Later from Shanghai Serum Bio-Technology
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Using Self-owned Funds to Pay Personnel Expenses for Investment Projects Financed by Raised Funds and Replacing with Equal Raised Funds
- Announcement on Renewing Engagement of Audit Institution for 2026
- Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Clinical Trials of Anti-bee Venom Serum
Follow Shanghai Serum Bio-Technology into a list and get an email when it puts out news.
Follow Shanghai Serum Bio-Technology